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Amyotrophic lateral sclerosis (ALS) is a devastating
disease that progresses from detachment of motor
nerve terminals to complete muscle paralysis and
lethal respiratory failure within 5 years of diagnosis.
Genetic studies have linked mutations in several
genes to ALS, and mice bearing mutations in SOD1
recapitulate hallmark features of the disease. We
investigated whether disease symptoms can be
ameliorated by co-opting the retrograde signaling
pathway that promotes attachment of nerve termi-
nals to muscle. We crossed SOD1G93A mice with
transgenic mice that express MuSK, a receptor tyro-
sine kinase that is required for retrograde signaling,
and we used histological and behavioral assays to
assess motor innervation and behavior. A 3-fold
increase in MuSK expression delayed the onset and
reduced the extent of muscle denervation, improv-
ing motor function for more than a month without
altering survival. These findings suggest that in-
creasing MuSK activity by pharmacological means
has the potential to improve motor function in ALS.INTRODUCTION
The withdrawal of motor axons from muscle is the first sign of
disease in familial and sporadic formsof amyotrophic lateral scle-
rosis (ALS), portending a progressive and devastating loss of
motor function that culminates in lethal muscle paralysis within
5 years of diagnosis (Fischer et al., 2004; Pasinelli and Brown,
2006; Schaefer et al., 2005). The mechanisms responsible for
axonwithdrawal arepoorly understood,but the lossof neuromus-
cular synapses is sufficient to cause muscle paralysis and there-
fore is central to the disease. Although the subsequent loss of
motor neurons has received more attention, preventing or delay-
ing motor neuron cell death without preserving neuromuscular
synapses cannot stop disease progression. Moreover, methods
designed to inhibit motor neuron cell death, either by blocking
cell death pathways or by providing broadly acting growth
factors, have had only a modest impact on disease progression
(Kostic et al., 1997; Pun et al., 2006; Sagot et al., 1995).
Dominant mutations in SOD1, TDP-43, FUS, and the recently
discovered C9orf72 gene are responsible for familial forms ofCelALS and together represent 17% of all cases of ALS (Chen-
Plotkin et al., 2010; Kwiatkowski et al., 2009; Majounie et al.,
2012; Pasinelli and Brown, 2006; Renton et al., 2011; Vance
et al., 2009). The pathological hallmarks of the disease are well
replicated in mice that overexpress mutant forms of SOD1 in
motor neurons, and therefore such mice provide an excellent
model system for studying the pathology of ALS and identifying
approaches to treat this devastating disease (Pasinelli and
Brown, 2006). Although cell types other than motor neurons,
including gray matter oligodendrocytes and microglia, con-
tribute to disease onset and progression (Ilieva et al., 2009;
Kang et al., 2010), dominant mutations in SOD1 act largely in
an autonomous manner within motor neurons, consistent with
the idea that ALS is primarily, though not entirely, a disease of
upper and lower motor neurons.
Skeletal muscles provide retrograde signals that promote the
differentiation and stabilization ofmotor nerve terminals (Burden,
1998; Sanes and Lichtman, 2001). In the absence of these
muscle-derived retrograde signals, developing motor axons
grow aimlessly within muscle and fail to form synapses. The pro-
duction of muscle-derived retrograde signals depends upon a
synaptic receptor tyrosine kinase, termed MuSK, and Lrp4,
a receptor for Agrin that forms a complex with MuSK (DeChiara
et al., 1996; Kim et al., 2008; Weatherbee et al., 2006; Zhang
et al., 2008; Yumoto et al., 2012). During normal development,
Lrp4/MuSK signaling initiates neuromuscular synapse forma-
tion, whereas the subsequent stabilization of nascent synapses
also requires neuronal Agrin, which binds to Lrp4 and strongly
stimulates MuSK (Kim and Burden, 2008; Zhang et al., 2008,
2011). In the absence of Agrin, neuromuscular synapses form,
but motor axon terminals subsequently withdraw, leading to
defective neuromuscular transmission and perinatal death
(Gautam et al., 1996; Lin et al., 2001, 2005; Misgeld et al.,
2005). Retrograde signaling also regulates the stability andmain-
tenance of synapses in adult animals, as interfering with MuSK
function in adult mice causes disassembly of neuromuscular
synapses (Hesser et al., 2006; Kong et al., 2004). Because a
failure to maintain neuromuscular synapses is central to all forms
of ALS, we tested whether increasing retrograde signaling in
SOD1 transgenic mice could stabilize neuromuscular synapses,
delay axonwithdrawal, and ameliorate the symptoms of disease.RESULTS
Previously, we found that a modest (3-fold) increase in MuSK
expression is sufficient to maintain neuromuscular synapses inl Reports 2, 497–502, September 27, 2012 ª2012 The Authors 497
Figure 1. MuSK Overexpression Delays the Onset and Reduces the Extent of Denervation in SOD1G93A Mice
(A) Denervation becomes evident at P120 in SOD1G93Amice and at P130 in SOD1G93Amice overexpressingMuSK. The extent of denervation remains lower in
mice overexpressing MuSK through P150.
(B) At P140, only 8% of synapses are denervated in SOD1G93A mice overexpressing MuSK, whereas 52% of synapses are denervated in SOD1G93A mice.
(C) Images of synapses from P140 mice stained with a-BGT to label AChRs and antibodies to NF and Syn to label motor axons and nerve terminals. Staining for
Syn and AChRs overlap at innervated synapses, whereas Syn staining is absent from denervated synapses, which retain a high density of AChRs. Error bars
are the SEM.
See also Figures S1 and S2.agrin mutant mice, thereby preventing perinatal lethality and
promoting postnatal survival (Kim and Burden, 2008). We there-
fore wondered whether increasingMuSK expression in a mouse
model of ALS would stabilize neuromuscular synapses, delay
motor axon withdrawal, and increase muscle function.
We crossed HSA::MuSK-L mice, which express 3-fold more
MuSK than wild-type (WT) mice, with SOD1G93A mice, and
used histological assays to compare the rate and extent of
denervation of the SOD1G93A and MuSK-L; SOD1G93A mice.
We stained whole mounts of the diaphragm muscle with anti-
bodies against synapsin (Syn) to label nerve terminals and with
a-bungarotoxin (a-BGT) to visualize acetylcholine receptors
(AChRs) in muscle. In WT and MuSK-L transgenic mice, nerve
terminals are apposed to AChRs, and the coincidence of Syn/
AChR staining defines innervated synaptic sites (Figure 1). In
SOD1G93Amice, axons from fast, fatigable motor neurons with-
draw early in disease (Pun et al., 2006). Axons from slow, nonfa-
tigable motor neurons are lost more slowly and compensate by
sprouting and temporarily reoccupying denervated synaptic
sites on fast myofibers (Pun et al., 2006). We first measured498 Cell Reports 2, 497–502, September 27, 2012 ª2012 The Authorthe number of synaptic sites that lacked Syn staining and were
therefore completely denervated. In SOD1G93A mice, denerva-
tion of the diaphragm muscle became evident at postnatal day
120 (P120) and the extent of denervation increased gradually
over the next 20 days, reaching a maximum of 50% at P140
(Figure 1), similar to the time course and extent of denervation
observed in other muscles (Schaefer et al., 2005). In contrast,
in SOD1G93A mice overexpressing MuSK, denervation of the
diaphragmmuscle began 10 days later, and the extent of dener-
vation remained <10% through P150 (Figure 1). By P160, the
extent of denervation increased and approached the level found
in SOD1G93A mice (Figures 1 and S1). These findings indicate
that MuSK overexpression protected synapses in SOD1G93A
mice from denervation by delaying the onset and decreasing
the extent of denervation for >40 days.
The remaining synapses included normally and partially inner-
vated synapses. At partially innervated synapses, Syn staining
incompletely overlapped the AChR-rich postsynaptic mem-
brane, leaving patches of the postsynaptic membrane devoid
of innervation (Figure 2). To determine whetherMuSK expressions
Figure 2. MuSK Overexpression Preserves Full Innervation in
SOD1G93A Mice
(A) In SOD1G93A mice, the number of normally innervated synapses falls to
20% by P140. In SOD1G93A mice overexpressing MuSK, nearly 80% of
synapses remain normally innervated at P140.
(B) Normally innervated, partially innervated, and denervated synapses are
distinguished by differences in overlap of staining for Syn and AChRs. Error
bars are the SEM.
See also Figures S1 and S2.
Figure 3. Grip Strength and Rota Rod Performance Are Enhanced in
SOD1G93A Mice Overexpressing MuSK
(A) The ability of SOD1G93A mice to cling to the wire grid declines rapidly
after P110.MuSK overexpression increases the length of time themice cling to
the wire grid.
(B) SOD1G93A mice fall from the Rota Rod beginning at P100, whereas mice
overexpressing MuSK begin to fall at P120. SOD1G93A mice overexpressing
MuSK remain on the rotating bar longer than the SOD1G93A mice at all
subsequent times. We analyzed 25–30 mice at P80–P120, 35 mice at P130,
40 mice at P140, and 32 mice at P150 and 32 at P160. Significantly different
values (p < 0.05) for SOD1G93A and SOD1G93A; HSA::MuSK-L mice are
indicated (*). Error bars are the SEM.
See also Figure S2 and Movie S1.preserved normal innervation, we measured the number of
synaptic sites that were normally innervated. Figure 2 shows
that the number of normally innervated synapses fell dramati-
cally after P110 in SOD1G93A mice, reaching a plateau of 20%
at P140. MuSK overexpression in SOD1G93A mice preserved
normal innervation: the fall in normal innervation was delayed,
and >60% of synapses remained normally innervated as late
as P150. These findings show that MuSK overexpression
preserves normally innervated synapses in SOD1G93A mice
for >40 days. MuSK overexpression may preserve innervation
by delaying denervation or increasing reinnervation, or both.
To determine whether the delay in onset and decrease in
extent of denervation were accompanied by improved motor
function, we used a Rota Rod and an inverted grid hanging
test to measure the motor performance of the SOD1G93A and
MuSK-L; SOD1G93A mice. Figure 3 shows that the MuSK-L;
SOD1G93A mice outperformed the SOD1G93A mice in both
tests of motor function. The MuSK-L; SOD1G93A mice clung
to the inverted grid longer than the SOD1G93A mice, beginning
at P120 and continuing through P160, the last time point that
we measured. Although the motor function of the MuSK-L;
SOD1G93Amice declined over time, the SOD1G93Amice over-
expressing MuSK outperformed the SOD1G93A mice by 2- to
3-fold at P120 and P130, and by 5- to 9-fold from P140 through
P160 (Figure 3A). Likewise, the MuSK-L; SOD1G93A mice out-
performed the SOD1G93A mice on the Rota Rod from P100Celthrough P160 (Figure 3B). Moreover, we were able to observe
these differences in motor behavior simply by monitoring the
mobility of mice in their housing (Movie S1). Nonetheless, the
benefit fromMuSK overexpression is not enduring, as the even-
tual withdrawal of nerve terminals and decrease in motor func-
tion led to death at a time point similar to that observed in the
SOD1G93A mice (Figure 4A).
DISCUSSION
We show that amodest increase inMuSK expression is sufficient
to maintain neuromuscular synapses in SOD1G93A mice,
delaying muscle denervation and improving muscle function
for >40 days. These findings indicate that the loss of motor nerve
terminals can be delayed by co-opting a retrograde signaling
pathway that normally functions to stimulate the differentiationl Reports 2, 497–502, September 27, 2012 ª2012 The Authors 499
Figure 4. MuSK Overexpression Does Not
Increase Longevity of SOD1G93A Mice
(A) The mean survival of SOD1G93A; HSA::MuSK-
L mice was 164.82 ± 1.83 days, which is not sig-
nificantly longer (p > 0.05) than that of SOD1G93A
mice (160.1 ± 2.09 days).
(B) Model for stabilizing motor nerve terminals. In
SOD1G93A mice, synapses become denervated
as motor neurons lose expression of receptors for
muscle retrograde signals, which promote differ-
entiation and muscle attachment of nerve termi-
nals. In SOD1G93A mice overexpressing MuSK,
retrograde signaling is enhanced, preserving
nerve terminal differentiation and muscle attach-
ment at times when receptor expression is
reduced but not absent. Error bars are the SEM.and stabilization of these terminals. As such, our findings sug-
gest a novel therapeutic approach to slow the steady decline
in muscle strength and motor function in ALS. Moreover,
because motor axon withdrawal is an early, characteristic, and
critical feature of disease in all forms of ALS, we expect that
increasing MuSK activity might provide benefit in both the
familial and sporadic forms of ALS.
The benefit fromMuSK overexpression is not permanent. The
eventual withdrawal of nerve terminals and loss ofmotor function
indicate that the motor neurons ultimately become so compro-
mised that the motor terminals can no longer be stabilized by
increasing MuSK signaling from muscle, suggesting that the
terminals eventually lose their ability to respond to critical
MuSK-dependent muscle-derived signals. Our recent studies
demonstrated that Lrp4 is a critical muscle-derived retrograde
signal that acts bidirectionally to coordinate pre- and postsyn-
aptic differentiation (Yumoto et al., 2012). A failure to transport
the Lrp4 receptor, or components that act downstream from
this receptor, within motor axons may ultimately render motor
neurons unresponsive to retrograde signaling (Figure 4B). Iden-
tification of the Lrp4 receptor might provide additional targets
that can be manipulated to strengthen and prolong the response
of compromised motor neurons. Alternatively, the eventual500 Cell Reports 2, 497–502, September 27, 2012 ª2012 The Authorswithdrawal of nerve terminals could be
caused by the death of motor neurons,
a late event in ALS that becomes ap-
parent in SOD1G93A mice 1–2 months
after denervation has reached a plateau
(Fischer et al., 2004). If so, combining
therapies that increase MuSK activity
with other therapies aimed at promoting
motor neuron survival might lengthen
the duration of benefit.
Aswith other receptor tyrosine kinases,
tyrosine phosphorylation and activation
of MuSK depend upon MuSK dimeriza-
tion (Stiegler et al., 2009), which is stimu-
lated by binding of Agrin to Lrp4 (Zhang
et al., 2011). Although MuSK overexpres-
sion is sufficient to promote MuSK dimer-
ization and increase MuSK kinase activity(Watty et al., 2000), it will be necessary to find alternatives
toMuSK overexpression to activate MuSK in vivo. Soluble forms
of neuronal Agrin or Lrp4 may stimulate MuSK in vivo, and a
screen for small-molecule activators of MuSK may identify new
agonists. Human single-chain variable-region antibodies (ScFv)
to MuSK stimulate MuSK tyrosine phosphorylation and AChR
clustering in cultured myotubes (Xie et al., 1997). The mecha-
nisms by which these agonist antibodies stimulate MuSK are
poorly understood, but they may provide an alternative means




Mice overexpressing human SOD1 (B6.Cg-Tg(SOD1-G93A)1Gur/J) were
purchased from Jackson Laboratory (Bar Harbor, ME) and crossed with
HSA::MuSK-L transgenic mice, which were also maintained on a C57BL/6J
background (Kim and Burden, 2008). SOD1G93A mice were genotyped
by PCR (50-CATCAGCCCTAATCCATCTGA-30 and 50-CGCGACTAACAATCAA
AGTGA-30). Primers for IL-2 (50-CTAGGCCACAGAATTGAAAGATCT-30 and
50-GTAGGTGGAAATTCTAGCATCATCC-30) were used as an internal control.
HSA::MuSK-L transgenic mice express 3-fold more MuSK than WT mice
(Kim and Burden, 2008). Genotyping was performed by PCR (50-GAAGC
AACCTTTCCTTCCTGAG-30 and 50-ATTTTCCCTGAGAGCATTGTCC-30). All
experiments were approved by the Animal Care and Use Committee of the
New York University School of Medicine.
Immunohistochemistry
Diaphragm muscles from adult mice were dissected and fixed for 1.5 hr at
room temperature in 1% formaldehyde in phosphate-buffered saline (PBS).
Muscles were washed three times for 15 min in PBS, incubated for 15 min
with 0.1 M glycine in PBS, and rinsed in PBS and 0.5% Triton X-100 (PBT).
Muscles were incubated for 1 hr in PBT containing 4% normal goat serum
(PBTG), and overlying connective tissue was diligently removed. Axons and
nerve terminals were labeled with rabbit polyclonal antibodies against neuro-
filament (NF, 1:3,000; Synaptic Systems, Goettingen, Germany) and Syn
(1:2,000; Synaptic Systems, Gottingen, Germany) overnight at 4C in PBTG.
After three 1 hr washes in PBT, the muscles were incubated at 4C overnight
with Alexa-488 goat anti-rabbit IgG (1:500; Invitrogen) and Alexa-594-conju-
gated-a-BGT (1:1,000 in PBTG; Invitrogen, San Diego, CA) to label AChRs.
Themuscles were washed three times with PBS over 1 hr, postfixed (1% form-
aldehyde in PBS) for 10min, rinsed in PBS, andmounted in Vectashield (Vector
Labs, Burlingame, CA) under a glass coverslip.
Diaphragm muscles from P90 to P160 WT, HSA::MuSK-L, SOD1G93A, and
SOD1G93A; HSA::MuSK-L mice were stained with Alexa-594-conjugated
a-BGT and antibodies to NF and Syn. Confocal images of diaphragm muscles
were captured on a Zeiss 510 confocal laser scanning microscope (Carl Zeiss
MicroImaging, Jena, Germany) using a 40X PlanApo objective. Images were
compiled into a reconstructed image, and the number of normally innervated,
partially innervated, and fully denervated synapses was quantified. For each
experiment, at least 100 synaptic sites were counted for each genotype, and
experiments were performed at least three times.
Survival
To measure longevity, we followed the survival of 300 animals (WT, n = 101;
HSA::MuSK-L, n = 86; SOD1G93A, n = 70; and SOD1G93A; HSA::MuSK-L,
n = 44) for up to 10 months. Kaplan Meier survival curves were generated
with the use of GraphPad Prism software.
Behavioral Tests
Motor function was assessed once per week on a Rota Rod (EZ-Rod 3.05;
Accuscan Instruments, Columbus, OH). In each experiment we measured
the running performance of at least six animals of each genotype from P80
to P160. Mice were placed on a Rota Rod (3.0 cm rotating cylinder) rotating
at 1 rpm, and the speed of rotation was gradually increased from 1 to
12 rpm over the course of 40 s and then maintained at 12 rpm for a maximum
of 5 min. We recorded the length of time the mice remained on the Rota Rod.
WT andHSA::MuSK-Lmice routinely ran for the full 5 min, yielding an assigned
value of 100%; the values for other mice were expressed relative to WT mice.
We assessed motor fatigue using an inverted grid hanging test (Kaja et al.,
2007). Individual mice were placed in the center of a wire grid, which was
mounted 80 cm above a laboratory bench. After gently inverting the grid, we
maintained the grid in an inverted position for a maximum of 60 s and recorded
the length of time the mice remained attached to the grid. WT mice routinely
remained attached to the grid for the duration and were assigned a value of
100%; the values for other mice were expressed relative to WT mice.
Statistical Analysis
All data are expressed as group means ± standard error of the mean (SEM).
For the Kaplan-Meier survival analysis, the log-rank test was used, and survival
curves were considered significantly different at p < 0.05. When appropriate,
a one-way analysis of variance followed by a Newman-Keuls, multiple-
comparison, post-hoc analysis was used to test for differences between
samples, and data were considered significantly different at p < 0.05.
hSOD1 Copy Number Assessment
To determine whether the SOD1G93A copy number changed during the
course of these experiments, we measured the copy number using a real-
time PCR assay. Genomic DNA was extracted from tails with the use of a
QIAGEN DNA extraction kit (QIAGEN, Valencia, CA). Brilliant II SYBR Green
QPCR Master Mix reagent (0.15–20 ng; Stratagene, Santa Clara, CA) wasCelused for real-time amplification of DNA. After heating at 50C for 2 min and
95C for 10 min, the DNA was amplified by 40 cycles of 95C for 15 s and
60C for 1 min, as suggested by Jackson Laboratories (Bar Harbor, ME). We
found that the copy number did not change during the course of these
experiments (Figure S2).
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